Quick Answer
PHIBRO ANIMAL HEALTH CORP reported Cash And Cash Equivalents At Carrying Value of $68.04 million for the year ending 2025.
- PHIBRO ANIMAL HEALTH CORP showed a decrease of -3.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from PHIBRO ANIMAL HEALTH CORP's annual report (Form 10-K), filed with the SEC on August 27, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $28.27 million | Q3 2013: $36.85 million | Q4 2013: $30.47 million | Q1 2014: $10.98 million | Q3 2014: $19.75 million | Q4 2014: $20.69 million | Q1 2015: $20.80 million | Q3 2015: $31.82 million | Q4 2015: $25.37 million | Q1 2016: $32.23 million | Q3 2016: $37.42 million | Q4 2016: $39.22 million | Q1 2017: $49.31 million | Q3 2017: $62.10 million | Q4 2017: $40.19 million | Q1 2018: $30.55 million | Q3 2018: $25.86 million | Q4 2018: $31.34 million | Q1 2019: $35.88 million | Q3 2019: $54.89 million | Q4 2019: $26.18 million | Q1 2020: $26.75 million | Q2 2020: $36.34 million | Q3 2020: $30.97 million | Q4 2020: $34.53 million | Q1 2021: $49.10 million | Q3 2021: $41.18 million | Q4 2021: $63.39 million | Q1 2022: $70.75 million | Q3 2022: $76.28 million | Q4 2022: $68.42 million | Q1 2023: $37.24 million | Q3 2023: $43.15 million | Q4 2023: $32.97 million | Q1 2024: $50.23 million | Q3 2024: $51.84 million | Q4 2024: $67.07 million | Q1 2025: $60.35 million | Q2 2025: $68.04 million | Q3 2025: $72.77 million | Q4 2025: $55.49 million.
- Over the full 15 years of available data (2011 to 2025), PHIBRO ANIMAL HEALTH CORP's Cash And Cash Equivalents At Carrying Value has grown by 40.0%.
- Historical annual values: Fiscal year 2025: $68.04 million | Fiscal year 2024: $70.61 million | Fiscal year 2023: $41.28 million | Fiscal year 2022: $74.25 million | Fiscal year 2021: $50.21 million | Fiscal year 2020: $36.34 million | Fiscal year 2019: $57.57 million | Fiscal year 2018: $29.17 million | Fiscal year 2017: $56.08 million | Fiscal year 2016: $33.61 million | Fiscal year 2015: $29.22 million | Fiscal year 2014: $11.82 million | Fiscal year 2013: $27.37 million | Fiscal year 2012: $53.90 million | Fiscal year 2011: $48.60 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: